Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MTZ vs GSK✓SelectedUSD · GSKMTZ vs GSK performance historyLatest closeAs of-3.24%11/16
Stock and ETF performance explorer

MTZ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+397.5%
GSK return
+107.3%
Excess return
+290.2%
Maximum drawdown
-67.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%-0.1%-3.2%-3.2%
7D-6.5%-1.3%-5.1%-6.2%
30D-7.4%+2.7%-10.2%-8.1%
3M-40.6%+2.7%-43.3%-41.2%
6M-57.4%+3.3%-60.7%-58.1%
YTD-18.6%+6.5%-25.1%-20.8%
1Y-8.0%+10.7%-18.7%-11.4%
3Y+231.7%+64.4%+167.4%+174.1%
5Y+84.9%+46.7%+38.2%+56.7%
10Y+397.5%+109.4%+288.1%+303.6%
All+397.5%+107.3%+290.2%+303.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling